Conditions: Hepatitis C, Chronic
Keywords: Chronic HCV infection raised ALT transaminitis HCV infection
Allocation: RANDOMIZED | Intervention model: 
Enrollment: 24
Healthy volunteers: no

Brief summary:
This study will evaluate the effect of PF-04136309 in patients with chronic hepatitic C virus infection and abnormal liver enzymes.

Detailed description:
Study recruitment was stopped on Dec 15, 2011 due to difficulty in enrolling the targeted number of patients. Subjects currently enrolled into the study will complete the study as per protocol. There were no safety concerns involved in the decision to stop enrollment. The new anticipated Last Subject Last Visit (LSLV) is February 2012.

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Placebo intervention 2: PF-04136309
Intervention descriptions: intervention 1: Take 4 capsules twice daily 12 hours apart with water. Swallow whole. intervention 2: Take 4 capsules twice daily 12 hours apart with water. Swallow whole.

Protocol document: